Fabienne Meggetto

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 4

Top Topics

Advanced Non Small Cell Lung Cancer

Tyrosine Kinase

Epidermal Growth Factor Receptor

Genome Wide Analysis

Top Venues

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Steffen Fuchs, Clara Danßmann, Filippos Klironomos, Annika Winkler, Jörg Fallmann, Louisa-Marie Kruetzfeldt, Annabell Krienelke-Szymansky, Julian Naderi, Stephan H Bernhart, Laura Grunewald, Konstantin Helmsauer, Elias Rodriguez-Fos, Marieluise Kirchner, Philipp Mertins, Kathy Astrahantseff, Christin Suenkel, Joern Toedling, Fabienne Meggetto, Marc Remke, Peter F Stadler, Patrick Hundsdoerfer, Hedwig E Deubzer, Annette Künkele, Peter Lang, Jörg Fuchs, Anton G Henssen, Angelika Eggert, Nikolaus Rajewsky, Falk Hertwig, Johannes Hubertus Schulte
Defining the landscape of circular RNAs in neuroblastoma unveils a global suppressive function of MYCN. Nature communications 14 (1) (2023)
Daugrois Camille, Bessiere Chloé, Dejean Sébastien, Anton Leberre Véronique, Commes Thérèse, Stephane Pyronnet, Pierre Brousset, Estelle Espinos, Brugiere Laurence, Fabienne Meggetto, Laurence Lamant
Gene Expression Signature Associated with Clinical Outcome in ALK-Positive Anaplastic Large Cell Lymphoma. Cancers 13 (21) (2021)
Elissa Andraos, Joséphine Dignac, Fabienne Meggetto
NPM-ALK: A Driver of Lymphoma Pathogenesis and a Therapeutic Target. Cancers 13 (1) (2021)
Domenico Sorrentino, Julie Frentzel, Géraldine Mitou, Rafael B Blasco, Avédis Torossian, Coralie Hoareau-Aveilla, Chiara Pighi, Manon Farcé, Fabienne Meggetto, Stéphane Manenti, Estelle Espinos, Roberto Chiarle, Sylvie Giuriato
High Levels of miR-7-5p Potentiate Crizotinib-Induced Cytokilling and Autophagic Flux by Targeting RAF1 in NPM-ALK Positive Lymphoma Cells. Cancers 12 (10) (2020)